Literature DB >> 225002

Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics.

K Shanmugaratnam, S H Chan, G de-Thé, J E Goh, T H Khor, M J Simons, C Y Tye.   

Abstract

A total of 363 cases of nasopharyngeal carcinoma (NPC) in Singapore were classified into squamous cell carcinoma (SCC; 73 cases), non-keratinizing carcinoma (NKC; 178 cases) and undifferentiated carcinoma (UC; 172 cases). Possible biological differences between these histologic types and between tumors with and without lymphocytic infiltration were investigated by correlations with survival rates and with selected epidemiologic, immunovirologic, and immunogenetic data on the disease. The 5-year survival rates following radiotherapy were 25.3% for all cases and 58.8% for tumors restricted to the nasopharynx. The 5-year survival rate for SCC was poorer than for the combined NKC and UC groups (p less than 0.05). The 3-year survival rate was better for tumors with lymphocytic infiltration (p less than 0.05), but there were no differences in the 5-year survivals. The survival rates were better in females (p less than 0.01) and in the younger age groups (p less than 0.01). There were no significant correlations between histopathology of NPC and the distributions of cases by age, sex, HLA antigen profiles, or cell-mediated immune status. Squamous cell carcinoma was associated with lower levels of antibodies to the Epstein-Barr nuclear antigen (p less than 0.05), but there were no differences with respect to antibodies against other EBV related antigens. These findings support the view that SCC, NKC, and UC of the nasopharynx, as defined in the WHO classification, are variants of a fairly homogeneous group of neoplasms in the Singapore population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225002     DOI: 10.1002/1097-0142(197909)44:3<1029::aid-cncr2820440335>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

1.  Update on nasopharyngeal carcinoma.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2007-11-27

2.  Nonkeratinizing undifferentiated nasopharyngeal carcinoma.

Authors:  Brandon R Peterson; Brenda L Nelson
Journal:  Head Neck Pathol       Date:  2012-09-27

3.  Pathobiology of selected tumors of the base of the skull.

Authors:  L Barnes
Journal:  Skull Base Surg       Date:  1991

4.  Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx.

Authors:  Edward B Stelow; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2017-02-28

5.  Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.

Authors:  Lu Liyan; Wang Si; Wang Qian; Shao Yuhui; Wei Xiaoer; Li Yuehua; Li Wenbin
Journal:  Clin Neuroradiol       Date:  2017-04-26       Impact factor: 3.649

6.  Impact of diabetes mellitus on treatment outcomes in patients with nasopharyngeal cancer.

Authors:  Hui Liu; Yunfei Xia; Nianji Cui
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

7.  Whole-brain changes in white matter microstructure after radiotherapy for nasopharyngeal carcinoma: a diffusion tensor imaging study.

Authors:  Fuhong Duan; Jingliang Cheng; Jianwei Jiang; Jun Chang; Yong Zhang; Shijun Qiu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-07       Impact factor: 2.503

8.  Carcinoma of the nasopharynx--comparison of the UICC and Ho clinical staging systems.

Authors:  S L Roth; G Bertram; H Sack
Journal:  Klin Wochenschr       Date:  1989-01-20

9.  Prognostic value of tumor volume in nasopharyngeal carcinoma.

Authors:  Jeong-Hyun Kim; Joon-Kyoo Lee
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

10.  Structural MRI research in patients with nasopharyngeal carcinoma following radiotherapy: A DTI and VBM study.

Authors:  Xi Leng; Peng Fang; Huan Lin; Jie An; Xin Tan; Chi Zhang; Donglin Wu; Wen Shen; Shijun Qiu
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.